Found: 8
Select item for more details and to access through your institution.
Interferon-activated tumor inhibition in vivo. Small amounts of interferon-gamma inhibit tumor growth by eliciting host systemic immunoreactivity.
- Published in:
- International Journal of Cancer, 1986, v. 37, n. 1, p. 141, doi. 10.1002/ijc.2910370122
- By:
- Publication type:
- Article
CCL16 Enhances the CD8+ and CD4+ T Cell Reactivity to Human Her-2 Elicited by Dendritic Cells Loaded with Rat Ortholog Her-2.
- Published in:
- International Journal of Immunopathology & Pharmacology, 2008, v. 21, n. 4, p. 867, doi. 10.1177/039463200802100411
- By:
- Publication type:
- Article
IL-10 Enhances CCL2 Release and Chemotaxis Induced by CCL16 in Human Monocytes.
- Published in:
- International Journal of Immunopathology & Pharmacology, 2005, v. 18, n. 2, p. 339, doi. 10.1177/039463200501800216
- By:
- Publication type:
- Article
Treatment of recurrent squamous cell carcinoma of the head and neck with low doses of interleukin-2 injected perilymphatically.
- Published in:
- 1988
- By:
- Publication type:
- journal article
PI3K/AKT signaling determines a dynamic switch between distinct KSRP functions favoring skeletal myogenesis.
- Published in:
- Cell Death & Differentiation, 2012, v. 19, n. 3, p. 478, doi. 10.1038/cdd.2011.117
- By:
- Publication type:
- Article
IL-6, but not IFN-γ, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencing.
- Published in:
- Leukemia (08876924), 2009, v. 23, n. 11, p. 2102, doi. 10.1038/leu.2009.139
- By:
- Publication type:
- Article
ROUS SARCOMA VIRUS-INDUCED TUMOURS IN MICE: II. CONTRIBUTION OF H-2 AND NON-H-2 ALLOANTIGEN BARRIERS TO TUMOUR IMMUNOGENICITY IN VIVO.
- Published in:
- International Journal of Immunogenetics, 1983, v. 10, n. 3, p. 209, doi. 10.1111/j.1744-313X.1983.tb00797.x
- By:
- Publication type:
- Article
Solid lipid nanoparticles of cholesteryl butyrate inhibit the proliferation of cancer cells in vitro and in vivo models.
- Published in:
- British Journal of Pharmacology, 2013, v. 170, n. 2, p. 233, doi. 10.1111/bph.12255
- By:
- Publication type:
- Article